13 11月 2018 by admin in UncategorizedComments Tempest Data Provide POC for PPAR Alpha’s Role in Cancer
06 11月 2018 by admin in UncategorizedComments resTORbio Appoints Michael Grissinger to its Board of Directors
06 11月 2018 by admin in UncategorizedComments Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018
05 11月 2018 by admin in UncategorizedComments Crescendo Biologics announces early licensing by Takeda of first oncology-targeted Humabody®
